R
Regeneron Pharmaceuticals, Inc. (REGN)
NMS – Real vaqt narxi. Valyuta: USD
632.90
+12.76 (2.06%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
631.38
-1.52 (-0.24%)
Bozordan keyin: Jun 26, 2026, 7:38 PM EDT
Find any stock by ticker or company name

NMS – Real vaqt narxi. Valyuta: USD
632.90
+12.76 (2.06%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
631.38
-1.52 (-0.24%)
Bozordan keyin: Jun 26, 2026, 7:38 PM EDT
This stock has a consensus price target of $812.17 based on the ratings of 29 analysts. The high is $1013.00 and the low is $587.00.
| Maqsad | Min. maqsadli narx | O‘rtacha maqsadli narx | Maks. maqsadli narx |
|---|---|---|---|
| Narx | $ 587 | $ 812.17 | $ 1013 |
| O’zgarish | -4.16% | 32.60% | 65.39% |
| Sana | O‘sish/pasayish potensiali | Tahlilchi firmasi | Maqsadli narx | Reyting o‘zgarishi | Reyting |
|---|---|---|---|---|---|
| 2026-05-19 | 41.82% | Canaccord Genuity | $1057 → $875 | Maintains | Buy |
| 2026-05-18 | 18.31% | BMO Capital | $900 → $730 | Maintains | Outperform |
| 2026-05-18 | 26.09% | Truist Securities | $796 → $778 | Maintains | Buy |
| 2026-05-18 | 37.76% | JP Morgan | $950 → $850 | Maintains | Overweight |
| 2026-05-18 | 38.57% | Piper Sandler | $875 → $855 | Maintains | Overweight |